Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies

References

• Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril 2002;77:1095–105
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Simbar M, Tohidi M, et al. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol 2011;9:39. doi: 10.1186/1477-7827-9-39
   PubMed Web of Science ®Google Scholar
• Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 2014;6:1–13
   Web of Science ®Google Scholar
• Diamanti-Kandarakis E. Insulin resistance in PCOS. Endocrine 2006;30:13–7
   PubMed Web of Science ®Google Scholar
• Galluzzo A, Amato MC, Giordano C. Insulin resistance and polycystic ovary syndrome. Nutr Metab Cardiovasc Dis 2008;18:511–8
   PubMed Web of Science ®Google Scholar
• Le Roith D, Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 2001;24:588–97
   PubMed Web of Science ®Google Scholar
• Association AD. Consensus development conference on insulin resistance: 5–6 November 1997. Diabetes Care 1998;21:310–4
   PubMed Web of Science ®Google Scholar
• Cefalu WT. Insulin resistance: cellular and clinical concepts. Exp Biol Med 2001;226:13–26
   PubMed Web of Science ®Google Scholar
• Hosseinpanah F, Barzin M, Keihani S, et al. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS prevalence study. Clin Endocrinol 2014;81:93–9
   PubMed Web of Science ®Google Scholar
• Vagiri D, Barletta C, Cioli I, Scavo D. Insulin resistance in obese and non-obese patients with polycystic ovary syndrome. Possible role in the pathogenesis of the disease. Minerva Endocrinol 1994;19:5–12
   PubMedGoogle Scholar
• Toprak S, Yönem A, Cakir B, et al. Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm Res 2000;55:65–70
   Google Scholar
• Ludvik B, Nolan JJ, Baloga J, et al. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 1995;44:1121–5
   PubMed Web of Science ®Google Scholar
• Zadeh-Vakili A, Tehrani FR, Hosseinpanah F. Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women. Diabetol Metab Syndr 2011;3:18. doi: 10.1186/1758-5996-3-18
   PubMed Web of Science ®Google Scholar
• Von Elm E, Altman DG, Egger M, et al. The Strengthening the reporting of observational studies in epidemiology [STROBE] statement: guidelines for reporting observational studies. BMJ 2007;335:806–8
   PubMed Web of Science ®Google Scholar
• Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. Published Online: Wiley Online Library; 2008
   Google Scholar
• Casella G, Berger RL. Inferência estatística. São Paulo: Cengage Learning; 2010
   Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13
   PubMedGoogle Scholar
• Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820–6
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557–60
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–101
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34
   PubMed Web of Science ®Google Scholar
• Singh S, Akhtar N, Ahmad J. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study. Diabetes Metab Syndr 2012;6:207–11
   PubMedGoogle Scholar
• Spanos N, Tziomalos K, Macut D, et al. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss. Obes Facts 2012;5:495–504. doi: 10.1159/000341579
   PubMed Web of Science ®Google Scholar
• Svendsen PF, Nilas L, Nørgaard K, et al. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Hum Reprod 2008;23:2113–21
   PubMed Web of Science ®Google Scholar
• Thomson R, Buckley J, Moran L, et al. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome. BJOG 2009;116:1242–50
   PubMed Web of Science ®Google Scholar
• Koiou E, Tziomalos K, Katsikis I, et al. Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome. Gynecol Endocrinol 2013;29:250–3
   PubMed Web of Science ®Google Scholar
• Hutchison SK, Stepto NK, Harrison CL, et al. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. J Clin Endocrinol Metab 2011;96:E48–56
   PubMed Web of Science ®Google Scholar
• Jayagopal V, Kilpatrick E, Holding S, et al. The biological variation of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 2002;87:1560–2
   PubMed Web of Science ®Google Scholar
• Altinkaya SÖ, Nergiz S, Küçük M, Yüksel H. Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2014;176:168–72
   PubMed Web of Science ®Google Scholar
• Ardawi MSM, Rouzi AA. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2005;83:1708–16
   PubMed Web of Science ®Google Scholar
• Cebeci F, Onsun N, Mert M. Insulin resistance in women with hirsutism. Arch Med Sci 2012;8:342–6
   PubMed Web of Science ®Google Scholar
• Martínez-García M, San-Millán J, Escobar-Morreale H. The R453Q and D151A polymorphisms of hexose-6-phosphate dehydrogenase gene (H6PD) influence the polycystic ovary syndrome (PCOS) and obesity. Gene 2012;497:38–44
   PubMed Web of Science ®Google Scholar
• Economou F, Xyrafis X, Livadas S, et al. In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls. Hormones (Athens) 2009;8:199–206
   PubMedGoogle Scholar
• Samy N, Hashim M, Sayed M, Said M. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis Markers 2009;26:163–70
   PubMed Web of Science ®Google Scholar
• Orio F, Palomba S, Cascella T, et al. Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? Reprod Biomed Online 2004;9:505–10
   PubMed Web of Science ®Google Scholar
• Schachter M, Raziel A, Friedler S, et al. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod 2003;18:721–7
   PubMed Web of Science ®Google Scholar
• Pasquali R, Gambineri A, Biscotti D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000;85:2767–74
   PubMed Web of Science ®Google Scholar
• Pangaribuan B, Yusuf I, Mansyur M, Wijaya A. Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with PCOS. Ther Adv Endocrinol Metab 2011;2:235–45
   PubMedGoogle Scholar
• Mokhlesi B, Scoccia B, Mazzone T, Sam S. Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women. Fertil Steril 2012;97:786–91
   PubMed Web of Science ®Google Scholar
• Martins W, Santana LF, Nastri CO, Ferriani FA, de Sa MF, Dos Reis RM. Agreement among insulin sensitivity indexes on the diagnosis of insulin resistance in polycystic ovary syndrome and ovulatory women. Eur J Obstet Gynecol Reprod Biol 2007;133:203–7
   PubMed Web of Science ®Google Scholar
• Zueff L, Martins W, Vieira C, Ferriani R. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome. Ultrasound Obstet Gynecol 2012;39:341–7
   PubMed Web of Science ®Google Scholar
• Carmina E, Bucchieri S, Esposito A, et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 2007;92:2500–5
   PubMed Web of Science ®Google Scholar
• Carmina E, Orio F, Palomba S, et al. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol 2005;152:389–94
   PubMed Web of Science ®Google Scholar
• Shroff R, Kerchner A, Maifeld M, et al. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab 2007;92:4609–14
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Samino S, Insenser M, et al. Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS. Clin Chem 2012;58:999–1009
   PubMed Web of Science ®Google Scholar
• Luque-Ramírez M, Alpañés M, Escobar-Morreale HF. The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism. Fertil Steril 2010;94:2214–21
   PubMed Web of Science ®Google Scholar
• Luque-Ramírez M, Mendieta-Azcona C, Álvarez-Blasco F, Escobar-Morreale HF. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome. Hum Reprod 2007;22:3197–203
   PubMed Web of Science ®Google Scholar
• Martínez-García MÁ, Luque-Ramírez M, San-Millán JL, Escobar-Morreale HF. Body iron stores and glucose intolerance in premenopausal women role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism. Diabetes Care 2009;32:1525–30
   PubMed Web of Science ®Google Scholar
• Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes 2012;19:81
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Lamendola C, Liu A, Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab 2011;96:E1756–60
   PubMed Web of Science ®Google Scholar
• Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840–6
   PubMed Web of Science ®Google Scholar
• Hosseinpanah F, Barzin M, Erfani H, et al. Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study. Clin Endocrinol 2014;81:52–7
   PubMed Web of Science ®Google Scholar
• Marshall JC, Dunaif A. All women with PCOS should be treated for insulin resistance. Fertil Steril 2012;97:18–22
   PubMed Web of Science ®Google Scholar
• Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989;38:1165–74
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 2012;33:981–1030
   PubMed Web of Science ®Google Scholar
• Ehrmann DA, Barnes RB, Rosenfield RL, et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141–6
   PubMed Web of Science ®Google Scholar
• Balen AH, Conway GS, Kaltsas G, et al. Andrology: polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995;10:2107–11
   PubMed Web of Science ®Google Scholar
• Mannerås-Holm L, Leonhardt H, Kullberg J, et al. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab 2010;96:E304–11
   PubMed Web of Science ®Google Scholar
• Toulis K, Goulis D, Farmakiotis D, et al. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update 2009;15:297–307
   PubMed Web of Science ®Google Scholar
• Attie AD, Scherer PE. Adipocyte metabolism and obesity. J Lipid Res 2009;50:S395–9
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Spiegelman BM. Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 1994;43:1271–8
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111–19
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Paterakis T, Kandarakis HA. Indices of low-grade inflammation in polycystic ovary syndrome. Ann N Y Acad Sci 2006;1092:175–86
   PubMed Web of Science ®Google Scholar
• Dunaif A, Segal KR, Shelley DR, et al. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 1992;41:1257–66
   PubMed Web of Science ®Google Scholar
• Garcia-Estevez D, Araujo-Vilar D, Fiestras-Janeiro G, et al. Comparison of several insulin sensitivity indices derived from basal plasma insulin and glucose levels with minimal model indices. Horm Metab Res 2003;35:13–7
   PubMed Web of Science ®Google Scholar
• Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008;294:E15–26
   PubMed Web of Science ®Google Scholar
• Louwers YV, Stolk L, Uitterlinden AG, Laven JS. Cross-ethnic meta-analysis of genetic variants for polycystic ovary syndrome. J Clin Endocrinol Metab 2013;98:E2006–12
   PubMed Web of Science ®Google Scholar
• Zhao Y, Qiao J. Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids 2013;78:755–60
   PubMed Web of Science ®Google Scholar
• Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Vol. 4. Boston: Blackwell Scientific Publication
   Google Scholar